Adani Enterp. 2575.50↑31.15(1.22%)
Adani Ports 733.00↑6.15(0.85%)
Apollo Hospitals 4641.05↑31.15(0.68%)
Asian Paints 3137.65↑9.25(0.30%)
Axis Bank 932.00↑5.05(0.54%)
B P C L 366.20↑1.90(0.52%)
Bajaj Auto 4640.25↑24.30(0.53%)
Bajaj Finance 6944.30↑39.80(0.58%)
Bajaj Finserv 1450.00↑10.85(0.75%)
Bharti Airtel 823.45↑5.50(0.67%)
Britannia Inds. 4621.05↑24.85(0.54%)
Cipla 948.90↓-2.45(-0.26%)
Coal India 241.50↓0.00(0.00%)
Divi's Lab. 3485.10↓-28.90(-0.82%)
Dr Reddy's Labs 4525.30↓-5.65(-0.12%)
Eicher Motors 3707.25↑16.90(0.46%)
Grasim Inds 1700.25↑11.95(0.71%)
H D F C 2683.65↑33.05(1.25%)
HCL Technologies 1142.50↑3.30(0.29%)
HDFC Bank 1630.00↑14.20(0.88%)
HDFC Life Insur. 584.70↑7.50(1.30%)
Hero Motocorp 2753.10↑7.95(0.29%)
Hind. Unilever 2673.50↑21.15(0.80%)
Hindalco Inds. 417.75↑4.20(1.02%)
ICICI Bank 952.10↑1.40(0.15%)
IndusInd Bank 1282.15↑14.10(1.11%)
Infosys 1326.45↑9.00(0.68%)
ITC 446.40↑2.80(0.63%)
JSW Steel 706.75↑5.05(0.72%)
Kotak Mah. Bank 1963.75↑18.70(0.96%)
Larsen & Toubro 2231.00↑12.55(0.57%)
M & M 1344.65↑62.80(4.90%)
Maruti Suzuki 9458.15↑58.20(0.62%)
Nestle India 21829.80↑248.05(1.15%)
NTPC 176.05↑1.55(0.89%)
O N G C 158.00↓-5.75(-3.51%)
Power Grid Corpn 237.05↓-0.25(-0.11%)
Reliance Industr 2522.90↑16.40(0.65%)
SBI Life Insuran 1218.95↑23.20(1.94%)
St Bk of India 589.65↑3.65(0.62%)
Sun Pharma.Inds. 953.00↓-16.90(-1.74%)
Tata Consumer 793.00↑3.30(0.42%)
Tata Motors 523.80↑5.35(1.03%)
Tata Steel 107.00↑0.60(0.56%)
TCS 3357.20↑28.30(0.85%)
Tech Mahindra 1117.00↑2.25(0.20%)
Titan Company 2761.00↑18.85(0.69%)
UltraTech Cem. 7814.65↑92.80(1.20%)
UPL 688.85↑0.75(0.11%)
Wipro 404.00↑2.30(0.57%)

Granules gets USFDA nod to market generic medicine for high blood pressure

The company has received approval from the US Food & Drug Administration (USFDA) to market Losartan Potassium tablets in strengths of 25 mg, 50 mg, and 100 mg, Granules India said

The Hyderabad-based company's product is bioequivalent to the Organon LLC's Cozaar tablets.

1 min read Last Updated : Feb 27 2023 | 12:00 PM IST

Drug firm Granules India on Monday said it has received approval from the US health regulator to market a generic product to treat high blood pressure.

The company has received approval from the US Food & Drug Administration (USFDA) to market Losartan Potassium tablets in strengths of 25 mg, 50 mg, and 100 mg, Granules India said in a regulatory filing.

The Hyderabad-based company's product is bioequivalent to the Organon LLC's Cozaar tablets.

According to IQVIA/IMS Health, the current annual US market for Losartan potassium tablets is around USD 336 million.

Shares of the company were trading 1.24 per cent down at Rs 281.75 apiece on the BSE.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)